[1] Terrault NA (2019) Hepatitis C elimination: challenges with under-diagnosis and under-treatment. F1000 Research, 8, F1000 Faculty Rev-54. [2] Polaris Observatory HCV Collaborators. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study (2017). Lancet Gastroenterol Hepatol,2017,2(3):161-176. [3] Country dashboard: China (2019), Polaris observatory. CDA foundation . https: //cdafound.org/dashboard/polaris/dashboard.html. [4] Rao HY, Duan ZP, Wang GQ, et al. Highlights of the guidelinesof prevention and treatment for hepatitis C (2019 version). Chin J Hepatol,2020,28(2):129-132. [5] 窦晓光, 丁洋. 我国丙型肝炎防治新策略探讨. 传染病信息,2016,29(02):71-72+100. [6] 刘芳, 孙秀华, 侯蕾蕾, 等. 2018-2019年菏泽市丙型肝炎报告病例特征分析. 社区医学杂志,2021,19(23):1387-1390. [7] 中联肝健康促进中心, 中华医学会肝病学分会, 中华医学会检验医学分会, 等. 中国丙型病毒性肝炎院内筛查管理流程(试行). 中华肝脏病杂志,2021,29(04):319-325. [8] 贺娜, 郝帅, 冯巩, 等. 医院内丙型肝炎诊治现状对院内消除策略的影响因素分析. 中华肝脏病杂志,2021,29(11):1053-1058. [9] 陈雨欣, 吴超. 医院内丙型肝炎筛查和转诊路径的建立与实施. 中华肝脏病杂志,2020,28(10):820-823. [10] 罗新华, 梁跃东, 彭虹, 等. 从全球丙型肝炎微消除模式到贵州省慢性丙型肝炎健康教育模式的探索. 中华肝脏病杂志,2020,28(10):816-819. [11] EL-AKEL W, EL-SAYED M H, EL KASSAS M, et al. National treatment programme of hepatitis C in Egypt: hepatitis C virus model of care. J Viral Hepat,2017,24(4):262-267 [12] MITRUKA K, TSERTSVADZE T, BUTSASHVILI M, et al. Launch of a nationwide hepatitis C elimination program— Georgia, April 2015. Mmwr Morb Mortal Wkly Rep, 2015,64(28):753-757. [13] Mbituyumuremyi A, Nuil Van JI, Umuhire J, et al. Controlling hepatitis C in Rwanda: a framework for a national response. Bull World Health Organ, 2018,96(1):51-58. [14] Olafsson S, Tyrfingsson T, Runarsdottir V, et al. Treatment as prevention for hepatitis C (TraP Hep C) -a nationwide elimination programme in iceland using direct-acting antiviral agents. J Intern Med,2018,283(5):500-507. [15] 杨仕贵. 消除病毒性肝炎公共卫生威胁,机遇与挑战并存.中华疾病控制杂志,2021,25(07):749-752. [16] Loreta AK, Sarah R, Sarah B, et al. Forecasting hepatitis C liver disease burden on real-life data. Does the hidden iceberg matter to reach the elimination goals?. Liver Int,2018,38(12): 2190-2198 [17] 饶慧瑛, 李明阳, 魏来. 消除丙型肝炎,我们的进展、挑战和希望.中华肝脏病杂志,2020,28(10):809-811. [18] Smith S, Harmanci H, Hutin Y, et al. Global progress on the elimination of viral hepatitis as a major public health threat: An analysis of WHO Member State responses 2017. JHEP Rep,2019,1(2):81-89 [19] Yehia BR, Herati RS, Fleishman JA, et al. Hepatitis C virus testing in adults living with HIV: a need for improved screening efforts. PLoS One,2014,9(7):e101554. [20] Chen ZW, Li Z, Wang QH, et al. Large Disparity between Prevalence and Treatment Rates for Hepatitis C in Western China. J Clin Transl Hepatol,2018,6(4):384-390. [21] Liu L, Xu H, Hu Y, et al. Hepatitis C screening in hospitals: find the missing patients. Virol J,2019,16(1):47. [22] Hei FX, Ye SD, Ding GW, et al. Epidemiological Analysis on Reported Hepatitis C Cases in China from 2012 to 2016. Biomed Environ Sci,2018,31(10):773-776. [23] World Hepatitis Alliance 2016. HCV Quest Global Patient Survey – China Report. https://www.worldhepatitisalliance.org/hcv-quest-global-patient-survey-china-en-report [24] 魏霞, 杨莉. 我国丙型病毒性肝炎治疗药物医疗保障政策. 临床药物治疗杂志,2021,19(12):1-5. |